Karen Firestone of Aureus Asset Management breaks down the case for biopharmaceuticals.
ValueAct takes a stake in Sanwa. How the activist can make a good company into a great one
The stock price and financial metrics show that Sanwa is a solid company. ValueAct can help it close the gap between good and great.
Utilities are the hottest part of the stock market right now, on track for their best year since 2000
Power and light and related stocks are also on course for their strongest year since 2000.
Tesla could have a tough time living up to the hype around its robotaxi event
Even as Tesla’s shares rip higher in September, Wall Street remains divided on the stock amid doubt around its long-term potential as a leading automaker.
Brokerages are slashing yields on cash, but these firms are still paying upward of 4% — for now
Financial service firms are trimming the yields they pay on uninvested cash, according to an analysis by Bank of America.
This old-line industrial stock is making a classic bearish-to-bullish reversal, says Carter Worth
Carter Worth breaks down the chart in Stanley Black & Decker.
The U.S. wants to triple nuclear power by 2050. America’s coal communities could provide a pathway
The U.S. needs to add 200 gigawatts of nuclear power, a senior official at the Department of Energy said.
Investors can depend on these frightless five stocks during a scary October for markets
CNBC PRO screened for historically stable stocks for a volatile October.
Two major deals coming soon may help jumpstart the IPO market
The S&P 500 has been cracking fresh highs, but the IPO market remains sluggish in 2024. Market observers hope two new deals could help thaw things out.
Using options to trade an index that’s become a swing trader’s dream
Nishant Pant breaks down the trade in the small cap benchmark Russell 2000.